U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
199201199201Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphine formulation: liquid vs. tablethttps://ClinicalTrials.gov/show/NCT00000320
199202199202Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000319
199203199203Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000318
199204199204Early Phase II Trials for Cocaine Medication Development - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Risperidone|Drug: Placebo|Behavioral: Relapse prevention counselinghttps://ClinicalTrials.gov/show/NCT00000317
199205199205Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2CompletedNo Results AvailableCocaine-Related DisordersDrug: Cocainehttps://ClinicalTrials.gov/show/NCT00000316
199206199206Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1CompletedNo Results AvailableCocaine-Related DisordersDrug: Cocainehttps://ClinicalTrials.gov/show/NCT00000315
199207199207M-CPP and Fenfluramine in Cocaine Addicts - 3CompletedNo Results AvailableCocaine-Related DisordersDrug: M-CPPhttps://ClinicalTrials.gov/show/NCT00000314
199208199208Predictive Values of Serotonergic Alterations for Outcome - 2TerminatedNo Results AvailableCocaine-Related DisordersDrug: Fenfluraminehttps://ClinicalTrials.gov/show/NCT00000313
199209199209Alterations in Serotonergic Functions in Cocaine Addicts - 1CompletedNo Results AvailableCocaine-Related DisordersDrug: M-CPPhttps://ClinicalTrials.gov/show/NCT00000312
199210199210Combining Behavioral Treatment With Agonist Maintenance - 1Active, not recruitingNo Results AvailableCocaine-Related Disorders|Opioid-Related Disorders|Substance-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000311
199211199211Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2TerminatedNo Results AvailableCocaine-Related DisordersDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00000310
199212199212Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1TerminatedNo Results AvailableCocaine-Related DisordersDrug: Risperidonehttps://ClinicalTrials.gov/show/NCT00000309
199213199213Dextroamphetamine-Cocaine Behavioral Intervention - 5CompletedNo Results AvailableCocaine-Related DisordersDrug: Dextroamphetamine|Drug: D-amphetamine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00000308
199214199214Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4CompletedNo Results AvailableAlcohol-Related Disorders|Cocaine-Related DisordersDrug: Naltrexonehttps://ClinicalTrials.gov/show/NCT00000307
199215199215Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3CompletedNo Results AvailableCocaine-Related Disorders|Opioid-Related DisordersDrug: Dextroamphetaminehttps://ClinicalTrials.gov/show/NCT00000306
199216199216Amphetamine Cocaine Interaction Study - 2TerminatedNo Results AvailableCocaine-Related DisordersDrug: Dextroamphetaminehttps://ClinicalTrials.gov/show/NCT00000305
199217199217Dextroamphetamine as an Adjunct in Cocaine Treatment - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Dextroamphetamine|Drug: D-Amphetamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00000304
199218199218Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6CompletedNo Results AvailableCocaine-Related DisordersDrug: Baclofenhttps://ClinicalTrials.gov/show/NCT00000303
199219199219Study Comparing Liquid and Tablet Buprenorphine Formulations - 5CompletedNo Results AvailableHeroin DependenceDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000302
199220199220Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4CompletedNo Results AvailableCocaine-Related DisordersDrug: Amantadinehttps://ClinicalTrials.gov/show/NCT00000301
199221199221Feasibility Study of Take-Home LAAM Medication - 3CompletedNo Results AvailableOpioid-Related DisordersDrug: LAAMhttps://ClinicalTrials.gov/show/NCT00000300
199222199222Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000299
199223199223Buprenorphine Combination Tablet Feasibility - 1CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphine/naloxonehttps://ClinicalTrials.gov/show/NCT00000298
199224199224Effects of Labetalol on Nicotine Administration in Humans - 14CompletedNo Results AvailableTobacco Use DisorderDrug: Labetalolhttps://ClinicalTrials.gov/show/NCT00000297
199225199225Role of Metabolites in Nicotine Dependence (4) - 13CompletedNo Results AvailableTobacco Use DisorderDrug: Cotinine fumaratehttps://ClinicalTrials.gov/show/NCT00000296
199226199226Progesterone Treatment in Female Smokers - 12CompletedNo Results AvailableTobacco Use DisorderDrug: Micronized Progesteronehttps://ClinicalTrials.gov/show/NCT00000295
199227199227Effects of Carvedilol on Cocaine Use in Humans - 11CompletedNo Results AvailableCocaine-Related DisordersDrug: Carvedilolhttps://ClinicalTrials.gov/show/NCT00000294
199228199228Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10CompletedNo Results AvailableCocaine-Related DisordersDrug: Nefazodonehttps://ClinicalTrials.gov/show/NCT00000293
199229199229Acute Withdrawal From Smoked Cocaine - 9CompletedNo Results AvailableCocaine-Related Disorders|Substance Withdrawal Syndrome|Substance-Related DisordersProcedure: Cocainehttps://ClinicalTrials.gov/show/NCT00000292
199230199230Effects of Labetalol on Human Cocaine Use - 8CompletedNo Results AvailableCocaine-Related DisordersDrug: Labetalolhttps://ClinicalTrials.gov/show/NCT00000291

* Görseller ve İçerik tekif hakkına sahip olabilir